Abstract
T-activin administered to rats after exposure to whole-body 1.5 Gy neutron- and 6 Gy X-radiation increases considerably the thymosin-like serum activity, accelerates cellularity restoration in the thymus and spleen, but does not influence the survival rate. Ionol administered prior to X-irradiation reduces the postirradiation hypercorticism reaction and the indirect effect of radiation on lymphoid organs which it is responsible for. The combined injection of ionol and T-activin increases the thymosin-like serum activity and spleen cellularity to the highest possible level and increases the survival rate of rats from 24 to 64 per cent and the lifespan up to 6 days.
Publication types
-
Comparative Study
-
English Abstract
MeSH terms
-
Adjuvants, Immunologic / administration & dosage
-
Adjuvants, Immunologic / pharmacology*
-
Adjuvants, Immunologic / therapeutic use
-
Adrenocortical Hyperfunction / etiology
-
Adrenocortical Hyperfunction / prevention & control*
-
Animals
-
Butylated Hydroxytoluene / administration & dosage
-
Butylated Hydroxytoluene / pharmacology
-
Drug Therapy, Combination
-
Male
-
Peptides / administration & dosage
-
Peptides / pharmacology*
-
Peptides / therapeutic use
-
Radiation Dosage
-
Radiation Injuries, Experimental / drug therapy*
-
Radiation Injuries, Experimental / mortality
-
Rats
-
Thymosin / blood
-
Thymus Extracts / administration & dosage
-
Thymus Extracts / pharmacology*
-
Thymus Extracts / therapeutic use
-
Thymus Gland / drug effects*
-
Thymus Gland / radiation effects*
-
Time Factors
-
Whole-Body Irradiation
Substances
-
Adjuvants, Immunologic
-
Peptides
-
Thymus Extracts
-
Butylated Hydroxytoluene
-
Thymosin
-
T-activin